CD 129 (Ranitidine 150 mg)

Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CD 129

Ranitidine hydrochloride

Imprint:

CD 129

Strength:

150 mg

Color:

Brown

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Dr. Reddy’s Laboratories Inc.

Inactive Ingredients:

magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
42291-0735	AvKare, Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.